Nipple Discharge: What Could Be Causing It

The Pattern Matters More Than the Color Alone

Breast specialists divide discharge into physiologic and pathologic patterns. ACR's 2022 criteria describe physiologic discharge as a presentation that generally does not need diagnostic imaging. Pathologic discharge does need imaging [1][2].

Features that raise concern are:

• Spontaneous flow without squeezing.
• One breast rather than both.
• One duct opening rather than several.
• Bloody or clear/serous fluid.
• A new lump, nipple inversion, or eczema-like nipple change.
• Older age or a prior breast-cancer history.

Color contributes information but does not diagnose the cause. Bloody discharge can occur with benign papilloma, and nonbloody discharge does not eliminate malignancy. A meta-analysis found bloody discharge associated with higher cancer risk than nonbloody discharge, but it was not specific enough to use alone [3].

Common Benign Causes

Galactorrhea

Galactorrhea is milk-like discharge outside ordinary pregnancy or breastfeeding. It is often bilateral and multiduct. Causes include pregnancy, persistent lactation, elevated prolactin, hypothyroidism, kidney disease, chest-wall stimulation, and medicines that alter dopamine or serotonin signaling [4][5].

The evaluation is not “order one prolactin and diagnose a tumor.” Clinicians review pregnancy possibility, medications, menstrual and sexual symptoms, headaches or vision changes, thyroid status, and renal function. A mildly elevated prolactin may need confirmation under appropriate collection conditions because stress and nipple stimulation can raise it [5].

Duct Ectasia

Duct ectasia involves widened ducts beneath the nipple and can produce thick green, brown, gray, or white discharge. It is often benign. Inflammation or infection can cause pain, redness, or a tender mass and changes the urgency.

Intraductal Papilloma

An intraductal papilloma is a growth within a breast duct and is a common cause of spontaneous unilateral bloody or serous discharge. Ultrasound, mammography, MRI, or ductoscopy may identify a lesion, but tissue sampling determines whether atypia or malignancy is present.

Management is not automatically the same for every papilloma. Imaging-pathology agreement, atypia, symptoms, lesion sampling, patient risk, and local breast-team practice affect whether surveillance, vacuum-assisted removal, or surgery is appropriate [6].

Pregnancy and Lactation

Colostrum or milk can appear during pregnancy, breastfeeding, and for a period after weaning. New bloody, single-duct, or mass-associated discharge during pregnancy or lactation still deserves clinical assessment; pregnancy does not rule out breast disease [7].

Medication-Related Galactorrhea

Medicines can raise prolactin or contribute to milk-like discharge. Important groups include:

• Antipsychotics, particularly prolactin-raising dopamine antagonists.
• Metoclopramide and domperidone.
• Some antidepressants.
• Opioids.
• Verapamil.
• Estrogen-containing treatment in some contexts.

Drug effects vary within a class and between patients [8][9]. Breast-cancer risk literature does not establish a drug-specific risperidone hyperprolactinemia rate; drug-frequency claims require drug-specific evidence.

Do not abruptly stop an antipsychotic, opioid, antidepressant, or anti-nausea medicine. The clinician who manages it can assess dose, alternatives, psychiatric or gastrointestinal stability, and the consequences of a change.

For antipsychotic-induced hyperprolactinemia, switching to a prolactin-sparing option or adding aripiprazole may be considered in selected patients. A dopamine agonist such as cabergoline is not a casual add-on because it can conflict with the therapeutic goals of dopamine-blocking treatment and requires psychiatric/endocrine coordination [4][5].

When Cancer Enters the Differential

Most nipple discharge evaluations do not end in a cancer diagnosis, but risk depends strongly on who was studied and whether a mass or imaging abnormality was present.

In a cohort of 280 patients with pathologic discharge, malignancy was associated with age, a palpable mass, and abnormal imaging. Among 48 patients without another clinical or imaging abnormality, one small ductal carcinoma in situ was found [10].

A 2023 systematic review focused on patients who underwent duct excision despite no clinical or radiologic suspicion. The weighted mean malignancy rate was 8.1%, meaning roughly nine of ten operations found a benign cause [11]. That result supports shared decision-making rather than claiming every persistent discharge requires immediate duct excision.

Potential malignant causes include ductal carcinoma in situ, invasive breast cancer, and Paget disease of the nipple. Paget disease may cause persistent scaling, crusting, redness, erosion, bleeding, or weeping centered on the nipple and is commonly associated with underlying breast carcinoma [12].

Imaging: The Current Age-Based Pathway

ACR recommends different initial tests by age and sex [1][2]:

Physiologic discharge without other concerning findings generally does not need diagnostic breast imaging [1].

MRI is not the routine first test. It can help when pathologic discharge persists and mammography plus ultrasound do not identify a cause. A review found that MRI identified an etiology in 56% to 61% of patients after negative conventional imaging [13]. A prospective study also found strong performance for identifying lesions requiring excision in that setting [14].

MRI can generate false positives and additional biopsies, so “highest sensitivity” is not enough to make it the first test for everyone. Ductography and ductoscopy are available in some centers but are not routine initial imaging under the ACR pathway.

What Cytology Can and Cannot Do

Examining discharge cells under a microscope may provide useful information when positive, but it cannot safely rule out malignancy.

A meta-analysis of 12 studies and 1,476 patients estimated pooled sensitivity of 63% and specificity of 95% for cytology [15]. A separate network meta-analysis found lower sensitivity than MRI and emphasized the different tradeoffs among mammography, ultrasound, cytology, MRI, and ductoscopy [16].

A negative cytology result therefore should not override a concerning clinical pattern or imaging finding. When imaging finds a target, image-guided core biopsy is generally more definitive.

Galactorrhea Laboratory Workup

For milk-like discharge, clinicians may use:

1. Pregnancy testing when applicable.
2. Medication and supplement review.
3. Serum prolactin.
4. Thyroid-stimulating hormone.
5. Renal function when clinically relevant.

Hyperprolactinemia guidance recommends confirming an unexplained elevation and evaluating physiologic, medication, thyroid, renal, and other causes before attributing it to a pituitary lesion [4][5].

There is no universal rule that every prolactin value above 100 ng/mL automatically mandates pituitary MRI. Concentration helps the differential, but assay effects, medication exposure, pregnancy, symptoms, and degree of elevation all matter. MRI is used when hyperprolactinemia remains unexplained, when medication timing and prolactin do not fit, or when neurologic features raise concern [4].

Headache, visual-field change, menstrual disruption, infertility, sexual dysfunction, or symptoms of hypogonadism add important context. Macroprolactin testing can be useful in selected patients with laboratory elevation but few compatible symptoms [5].

Treatment Depends on the Cause

Physiologic Discharge

Avoid repeated squeezing, which can perpetuate discharge. Review medications and return if the pattern becomes spontaneous, unilateral, bloody, mass-associated, or otherwise changes.

Medication-Related Galactorrhea

The prescribing clinician decides whether to observe, reduce a dose, switch treatment, or coordinate endocrine care. The benefit of the original medicine matters. Treatment should not create psychiatric relapse, uncontrolled nausea, or opioid withdrawal to resolve a benign symptom.

Prolactinoma

When a prolactinoma is confirmed, dopamine agonist therapy is usually first-line. Cabergoline is often preferred because of effectiveness and tolerability, with dosing and follow-up directed by endocrinology [4].

Papilloma or Other Imaging Target

An image-guided biopsy establishes histology. Excision decisions depend on atypia, concordance, symptoms, sampling completeness, and patient factors [6]. Persistent discharge with negative imaging may lead to MRI, surveillance, ductoscopy, or duct excision after breast-specialist review.

Infection

Redness, warmth, tenderness, fever, or an abscess-like lump requires assessment for mastitis or abscess. Treatment may include antibiotics and drainage depending on findings.

Malignancy

Treatment follows the specific histology and stage. Discharge itself does not determine whether surgery, radiation, endocrine therapy, chemotherapy, or another treatment is appropriate.

Men and Transgender Patients

Pathologic discharge can occur in women, men, transfeminine patients, and transmasculine patients. ACR includes all of these groups in its imaging framework [1].

Because male pathologic nipple discharge has a meaningful association with breast cancer, ACR recommends mammography or tomosynthesis for men age 25 and older, with ultrasound added when indicated [1]. Hormone use, prior chest surgery, and the amount of remaining breast tissue affect the clinical context but do not remove the need to evaluate a pathologic pattern.

When to Seek Care

Arrange prompt evaluation for:

• Spontaneous discharge from one breast.
• Bloody or clear single-duct discharge.
• A new breast or underarm lump.
• New nipple inversion.
• Persistent nipple scaling, crusting, erosion, or bleeding.
• Discharge in a male patient.
• Headache or vision change with galactorrhea.
• Fever, spreading redness, marked tenderness, or severe illness.

Routine evaluation is still appropriate for persistent bilateral milky discharge, even when it is likely benign. Bring a complete medication and supplement list and note whether discharge occurs without touching the breast.

Bottom Line

Nipple discharge is a symptom pattern, not a diagnosis. Bilateral multiduct milk-like discharge points toward pregnancy, lactation, medication effects, thyroid disease, or hyperprolactinemia. Spontaneous unilateral single-duct bloody or serous discharge is pathologic and needs age-appropriate imaging.

The safest current pathway avoids two extremes: dismissing all discharge as benign and sending every patient directly to MRI or surgery. History, examination, age-based mammography and ultrasound, selective MRI, and tissue diagnosis when a target is found provide a stronger route.